Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits

British Journal of Biomedical Science

Volumn 58, Issue 4, 2001, Pages 217-225

  Zhang, B ^a   Fan, P ^a   Tanaka, H ^a   Saku, K ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin antagonists and inhibitors; Blood pressure; Cholesterol; Dietary; Insulin; Rabbits; Receptors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; OLMESARTAN;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERLIPIDEMIA; INSULIN CLEARANCE; INSULIN METABOLISM; INSULIN SENSITIVITY; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RABBIT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GLUCOSE TOLERANCE TEST; HYPERCHOLESTEROLEMIA; IMIDAZOLES; INSULIN; RABBITS; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0035677107     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Insulin resistance in essential hypertension
2. Insulin, insulin sensitivity and hypertension
3. The Zucker fatty rat as a genetic model of obesity and hypertension
4. Relationship between blood pressure, insulin concentration, and insulin action in SHR and WKY rats
5. Insulin and blood pressure regulation
6. Resistance to insulin-stimulated glucose uptake in patients with hypertension
7. Insulin and blood pressure in obesity
8. Metabolic considerations in the choice of therapy for the patient with hypertension
9. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia
10. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
11. The advantages of angiotensin II antagonism
12. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension
13. ACE inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients
14. Angiotensin-converting enzyme and the cough reflex
15. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor
16. The unusual substrate specificity and the distribution of human angiotensin I converting enzyme
17. Angiotensin II receptors and angiotensin II receptor antagonists
18. The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonists
19. Effects of Losartan on insulin sensitivity in hypertensive subjects
20. The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension
21. Effects of angiotensin II-receptor blockade with Losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents
22. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
23. Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients
24. Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease
25. Insulin resistance observed in WHHL rabbits
26. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit
27. Can antihypertensive drugs reduce atherosclerosis and its clinical complications?
28. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: A minimal model analysis
29. Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits
30. Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril
31. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats
32. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
33. Eine neue bestimmung der neutralfette in blutserum und gewebe. I. Mit prinzip, durchfuhrung und besprechung der methode
34. 2+, and an anion-exchange resin
35. Effects of troglitazone on serum lipids, lipoproteins, and hyperinsulinemia in Watanabe heritable hyperlipidemic rabbits
36. 125I-aldosterone RIA kits
37. Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin
38. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung
39. Quantitative estimation of insulin sensitivity
40. Quantitative estimation of beta cell sensitivity to glucose in the intact organism
41. Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril
42. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet
43. Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats
44. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterolfed rabbits
45. Renin as a risk factor for atherogenesis. Part 2. Effects of hypercholesterolemia and hyporeninemia in the rabbit
46. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla
47. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor
48. Serum insulin concentration, insulin release and degradation, glucose tolerance and in vivo insulin sensitivity in cholesterol-fed rats